throbber
Case 3:22-cv-04465-CRB Document 24 Filed 10/12/22 Page 1 of 31
`
`
`Jonas B. Jacobson (Cal. Bar No. 269912)
`jonas@dovel.com
`Simon Franzini (Cal. Bar No. 287631)
`simon@dovel.com
`
`DOVEL & LUNER, LLP
`201 Santa Monica Blvd., Suite 600
`Santa Monica, California 90401
`Telephone: (310) 656-7066
`
`
`
`UNITED STATES DISTRICT COURT
`NORTHERN DISTRICT OF CALIFORNIA
`
`Krystal Lopez, individually and on behalf of
`all others similarly situated,
`
` Plaintiff,
`
`vs.
`
`Zarbee’s, Inc.,
`
` Defendant.
`
`Case No. 3:22-cv-04465-CRB
`
`FIRST AMENDED CLASS ACTION
`COMPLAINT
`DEMAND FOR JURY TRIAL
`
`
`
`
`
`
`
`
`
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`
`

`

`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`
`Case 3:22-cv-04465-CRB Document 24 Filed 10/12/22 Page 2 of 31
`
`
`
`I. 
`II. 
`III. 
`IV. 
`
`B. 
`C. 
`
`Table of Contents
`Introduction. ............................................................................................................................... 1 
`Parties. ........................................................................................................................................ 2 
`Jurisdiction, venue, and divisional assignment. ......................................................................... 2 
`Facts. .......................................................................................................................................... 2 
`It is important to consumers that over-the-counter melatonin is accurately
`A. 
`dosed and labelled. ......................................................................................................... 2 
`The FDA does not allow melatonin to be unreasonably overdosed............................... 5 
`Scientific research reveals serious problems with the accuracy of melatonin
`dosing and labelling in Canada. Scientists warn that the same is likely true of
`some U.S. brands. .......................................................................................................... 6 
`Zarbee’s markets melatonin for children and sells melatonin supplements to
`millions of U.S. consumers. ........................................................................................... 7 
`Scientific testing reveals that, unlike other manufacturers, Zarbee’s Melatonin
`has an unreasonable excess of melatonin. ...................................................................... 9 
`Zarbee’s labelling is false and misleading to reasonable consumers. .......................... 11 
`F. 
`Zarbee’s overcharges millions of consumers. .............................................................. 12 
`G. 
`Ms. Lopez was misled and harmed by Zarbee’s misleading labelling. ....................... 13 
`H. 
`Plaintiff has no adequate remedy at law. ..................................................................... 14 
`I. 
`Class action allegations. ........................................................................................................... 15 
`V. 
`VI.   Claims. ..................................................................................................................................... 17 
`Count 1: Violations of State Consumer Protection Acts .......................................................... 17 
`Count 2: Violation of California Unfair Competition Law (UCL) .......................................... 18 
`Count 3: Violation of California’s False Advertising Law (FAL) ........................................... 19 
`Count 4: Violation of the California Consumers Legal Remedies Act (CLRA) ..................... 20 
`Count 5: Breach of Express Warranty ..................................................................................... 21 
`Count 6: Unjust Enrichment/Quasi-Contract ........................................................................... 22 
`VII. Jury Demand. ............................................................................................................................ 22 
`VIII. Prayer for Relief. ...................................................................................................................... 22 
`
`
`D. 
`
`E. 
`
`
`
`First Amended Complaint
`
`i
`
`Case No. 3:22-cv-04465-CRB
`
`

`

`Case 3:22-cv-04465-CRB Document 24 Filed 10/12/22 Page 3 of 31
`
`
`
`I.
`
`Introduction.
`1.
`Melatonin is a neurohormone that regulates the brain’s sleep cycle. Millions of
`consumers take over-the-counter melatonin supplements to help them sleep. Because melatonin
`alters brain chemistry, it is important that these supplements are accurately dosed and labelled.
`2.
`A few years ago, scientists tested Canadian melatonin supplements and found that, for
`a number of brands, the true amount of melatonin varied wildly from the label. Scientists, the
`National Institutes of Health, and consumer advocates have warned that the same is true in the U.S.
`3.
`Zarbee’s is a major U.S. brand of melatonin supplements, sold nationwide at retailers
`like Walmart, Kroger, and Target. Many Zarbee’s melatonin products are specifically marketed for
`young children. Each bottle claims to have a specific dose of melatonin per serving. For example:
`
`4.
`Like millions of other consumers, Ms. Lopez bought Zarbee’s melatonin for her
`children and trusted the accuracy of Zarbee’s dosing and labelling. To determine how much
`melatonin is really in Zarbee’s, a university mass-spectrometry laboratory tested multiple bottles,
`including her bottle. The results were alarming. The true amount of melatonin in her bottle was
`216% of the claimed amount. The tested bottles had far more melatonin than the amount on the label
`(and far more melatonin than the “reasonable excess” permitted by the FDA).
`5.
`Zarbee’s systematically misrepresents how much melatonin is in the supplements it
`sells. Consumers are being misled and overcharged, and children are being put at risk.
`
`First Amended Complaint
`
`1
`
`Case No. 3:22-cv-04465-CRB
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`
`

`

`Case 3:22-cv-04465-CRB Document 24 Filed 10/12/22 Page 4 of 31
`
`
`
`II.
`
`Parties.
`6.
`Plaintiff Krystal Lopez is domiciled in Salinas, California. She purchased a bottle of
`Zarbee’s Children’s Sleep Melatonin in California.
`7.
`The proposed class includes citizens of every state.
`8.
`Defendant Zarbee’s Inc. is a Delaware corporation with its principal place of business
`at 11650 State St. #101, Draper, Utah 84020.
`III.
`Jurisdiction, venue, and divisional assignment.
`9.
`This Court has subject matter jurisdiction under 28 U.S.C. § 1332(d)(2). The amount
`in controversy exceeds $5,000,000, exclusive of interest and costs, and the matter is a class action in
`which one or more members of the proposed class are citizens of a state different from Defendant.
`10.
`The Court has personal jurisdiction over Defendant because Defendant sold Zarbee’s
`melatonin products to consumers in California, including to Plaintiff.
`11.
`Venue is proper under 28 U.S.C. § 1391(b)(1) and 28 U.S.C. § 1391(d) because
`Defendant would be subject to personal jurisdiction in this District if this District were a separate
`state, given that Defendant sold Zarbee’s melatonin products to consumers in this District,
`including Plaintiff. Venue is also proper under 28 U.S.C. § 1391(b)(2) because a substantial part
`of Defendant’s conduct giving rise to the claims occurred in this District, including Defendant’s
`sale to Plaintiff.
`12.
`Divisional Assignment. This action arose in Monterey County (San Jose Division).
`Ms. Lopez purchased Zarbee’s melatonin while living in Salinas (in Monterey County). Thus, a
`substantial part of the events giving rise to the claim occurred in Monterey County.
` IV. Facts.
`A.
`It is important to consumers that over-the-counter melatonin is accurately dosed
`and labelled.
`13. Melatonin (N-acetyl-5-methoxytryptamine) is a neurohormone produced by the pineal
`gland in the brain. It regulates the brain’s circadian rhythm and sleep cycle.
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`
`First Amended Complaint
`
`2
`
`Case No. 3:22-cv-04465-CRB
`
`

`

`Case 3:22-cv-04465-CRB Document 24 Filed 10/12/22 Page 5 of 31
`
`
`
`The chemical structure of melatonin
`14. Millions of U.S. consumers take melatonin supplements to treat sleep problems,
`anxiety, and other issues. Melatonin is one of the most popular over-the-counter supplements in the
`U.S., and its use has “significantly increased” in the last 20 years. 1 Its use to help children sleep is
`becoming increasingly popular too, which concerns health experts. 2
`15.
`As scientists explained in the Journal of Clinical Sleep Medicine, because melatonin is
`“self-prescribed” (i.e., purchased directly by consumers who are not experts), it is particularly
`“important that labels are informative and representative of the product,” i.e., that the “label claim
`values for the active ingredient are accurate.” 3
`16.
`In particular, it is important to consumers that melatonin is not excessively dosed,
`compared to what is represented on the label. The likelihood of side effects from melatonin increases
`with the dosage. Side effects of melatonin include headaches, dizziness, nausea, or excessive or
`unwanted sleepiness. 4 As the Texas Health hospital network explains, a “lower dose” will reduce
`the risk of “side effects” and thus “using the lowest effective dose will give you the best outcomes
`while keeping any undesirable side effects at bay.” 5 And as another major manufacturer of melatonin
`
`
`1 JAMA Research Letter, Trends in Use of Melatonin Supplements Among US Adults, 1999-
`2018, 327(5) JAMA 483 (2022).
`2 The New York Times, Parents Are Relying on Melatonin to Help Their Kids Sleep. Should
`They?, https://www.nytimes.com/2020/05/18/parenting/melatonin-sleep-kids.html
`3 Erland, L. & Saxena, P., Melatonin Natural Health Products and supplements: Presence of
`serotonin and significant variability of melatonin content, 13 Journal of Clinical Sleep Medicine
`275–281 (2017).
`4 NIH National Library of Medicine Medline Plus, Melatonin,
`https://medlineplus.gov/druginfo/natural/940.html
`5 https://www.texashealth.org/areyouawellbeing/Health-and-Well-Being/Is-It-Safe-to-Take-
`Melatonin-Every-Night
`First Amended Complaint
`
`Case No. 3:22-cv-04465-CRB
`
`3
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`
`

`

`Case 3:22-cv-04465-CRB Document 24 Filed 10/12/22 Page 6 of 31
`
`
`
`supplements states: “The likelihood of these side effects [headaches, upset stomach, grogginess,
`sleeplessness, irritability and dizziness] increases with the dosage.” 6 This is why “[m]any experts
`recommend starting with the smallest available dosage — 0.5 milligrams to 1 milligram.” 7
`17.
`These concerns are especially serious for children. When melatonin is given to
`children, the American Academy of Pediatricians (AAP) warns that “quality may not be the same for
`all melatonin products” and recommends its use only “cautiously and carefully.” The AAP
`recommends: “Start with the lowest dosage. Many children will respond to a low dose (0.5 mg or 1
`mg).” 8
`18. When melatonin is falsely labeled, consumers unwittingly take “higher doses” that
`increase the risk of “unpleasant/unexpected side effects.” 9 And regardless of side effects, consumers
`don’t want to take excessive amounts of a neurohormone that alters brain chemistry. Consumers
`certainly don’t want to give such excessive dosages to their children.
`19.
`In addition, it is important to consumers that melatonin is accurately (not excessively)
`dosed because the long-term safety of melatonin is not established, and higher doses carry greater
`long-term safety concerns. As the National Institutes of Health explains, the long-term safety of
`melatonin remains unknown:
`For melatonin supplements, particularly at doses higher than what the body normally
`produces, there’s not enough information yet about possible side effects to have a clear
`picture of overall safety. Short-term use of melatonin supplements appears to be safe for most
`people, but information on the long-term safety of supplementing with melatonin is lacking.10
`20.
`Long-term safety is especially uncertain for children:
`
`
`6 https://www.zzzquil.com/en-us/faq/zzzquil-pure-zzzs-melatonin-faq (made by Proctor &
`Gamble)
`7 The New York Times, Melatonin Isn’t a Sleeping Pill. Here’s How to Use It,
`https://www.nytimes.com/2022/01/11/well/mind/melatonin-sleep-insomnia.html
`8 Melatonin for Kids: What Parents Should Know About This Sleep Aid, healthychildren.org
`(from the American Academy of Pediatricians), https://www.healthychildren.org/English/healthy-
`living/sleep/Pages/melatonin-and-childrens-sleep.aspx
`9 Grigg-Damberger, M. & Ianakieva, D., Poor quality control of over-the-counter melatonin:
`What they say is often not what you get, 13 Journal of Clinical Sleep Medicine 163–165 (2017).
`10 https://www.nccih.nih.gov/health/melatonin-what-you-need-to-know
`First Amended Complaint
`4
`Case No. 3:22-cv-04465-CRB
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`
`

`

`Case 3:22-cv-04465-CRB Document 24 Filed 10/12/22 Page 7 of 31
`
`
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`
`Melatonin supplements at normal doses appear to be safe for most children for short-term use,
`but there aren’t many studies on children and melatonin. Also, there’s little information on the
`long-term effects of melatonin use in children. Because melatonin is a hormone, it’s possible
`that melatonin supplements could affect hormonal development, including puberty, menstrual
`cycles, and overproduction of the hormone prolactin, but we don’t know for sure.11
`21. Melatonin for adults is available on the market in a range of doses, e.g., 1 mg, 3 mg, 5
`mg or 10 mg. This is because consumers want to make their own, informed decision about the
`dosage that is right for them. When marketed for children, melatonin is generally only available at
`lower doses (e.g., 1 mg or 0.5 mg per serving), because higher doses are not generally recommended.
`No consumer wants an informed choice to be robbed from them by inaccurate labelling and dosing.
`For example, if a consumer purchases a 1 mg dose (and not a higher dose), this is because they want
`1 mg and no more. This choice is objectively reflected by their decision to purchase 1 mg, instead of
`a higher dose. Each consumer has the right to make their own, informed choice about what dosage to
`purchase and ingest (or provide to their children). No reasonable consumer wants to be tricked into
`taking a higher dose when they wanted.
`B.
`The FDA does not allow melatonin to be unreasonably overdosed.
`22.
`The FDA recognizes that consumers have a right to make an informed decision about
`how much of supplements, like melatonin, they are really taking. The FDA also recognizes that some
`supplements, such as melatonin, degrade over time, such that a product that contains a certain amount
`of a supplement when it is put on the shelves might have less of that supplement at expiration.
`23.
`The FDA balanced these competing considerations by providing that, for dietary
`supplements “reasonable excesses over labeled amounts are acceptable within current good
`manufacturing practice,” 21 C.F.R §101.36(f)(1), i.e., within amounts reasonably necessary to ensure
`that the product “meets the amount specified on the label throughout the product's shelf life.” Current
`Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for
`Dietary Supplements, 72 Fed. Reg. 34752, 34884 (June 25, 2007). But, as the FDA provides,
`manufacturers are prohibited from adding “unspecified amounts [of an ingredient] that would be in
`
`
`11 https://www.nccih.nih.gov/health/melatonin-what-you-need-to-know
`First Amended Complaint
`5
`Case No. 3:22-cv-04465-CRB
`
`

`

`Case 3:22-cv-04465-CRB Document 24 Filed 10/12/22 Page 8 of 31
`
`
`
`excess of the amount actually needed to meet the label declaration.” 68 Fed. Reg. 12158, 12158 (Mar.
`13, 2003). So, an excess is not a “reasonable excess” (and violates FDA regulations) if the excess is
`materially in excess of the amount actually needed to meet the amount declared on the label
`throughout the product’s shelf life.
`24.
`The FDA does not review and approve any particular overages for dietary
`supplements—the duty falls on manufacturers to assure compliance with the “reasonable excess”
`limit.
`
`25.
`Certain U.S. manufacturers comply with the FDA’s limits. For context, Plaintiffs’
`testing has shown that melatonin by other U.S. manufacturers who do not unreasonably overdose
`their products is put on shelves with an excess amounting to approximately 10-15% more than the
`amount declared on the label. This excess is reasonable because, by the time the shelf life ends, the
`product has approximately the amount of melatonin that is declared on the label. In this situation, the
`excess is not materially in excess of the amount actually needed to meet the label declaration, and so
`it complies with the FDA’s mandates.
`26.
`By contrast, if a manufacturer includes materially more melatonin than is actually
`needed to ensure that by the time the shelf life ends, the product has approximately the amount of
`melatonin that is declared on the label, this violates FDA’s mandates. Because such an excess is
`more than the amount actually needed to meet the label declaration, it is not a “reasonable” excess. It
`is therefore not permitted under the FDA regulations (and is instead prohibited).
`C.
`Scientific research reveals serious problems with the accuracy of melatonin
`dosing and labelling in Canada. Scientists warn that the same is likely true of
`some U.S. brands.
`27.
`In 2017, a study of Canadian melatonin brands found “high variability, ranging from
`−83% to +478%, of the labelled concentration of melatonin content in melatonin supplements.” 12
`For over 70% of the tested brands, the true amount of melatonin varied more than 10% from the
`listed amount. The amount of melatonin also varied highly between different lots (manufacturing
`
`
`12 Lauren, Melatonin Natural Health Products and supplements, 13 Journal of Clinical Sleep
`Medicine at 276.
`First Amended Complaint
`
`Case No. 3:22-cv-04465-CRB
`
`6
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`
`

`

`Case 3:22-cv-04465-CRB Document 24 Filed 10/12/22 Page 9 of 31
`
`
`
`batches) of the same product. The researchers concluded that “manufacturers require increased
`controls to ensure melatonin supplements” are accurately labelled.
`28.
`U.S. scientists warned that this Canadian study “herald[s] what may also be true in
`OTC melatonin supplements marketed in the United States.” 13 Likewise, the National Institutes of
`Health has warned that “some melatonin supplements may not contain what’s listed on the product
`label.” 14 And Consumer Reports warned: “The findings … offer the latest proof of something
`supplement industry critics have long warned about: When it comes to this poorly regulated corner of
`modern medicine, consumers often don’t know what they’re buying.” 15
`D.
`Zarbee’s markets melatonin for children and sells melatonin supplements to
`millions of U.S. consumers.
`29.
`Zarbee’s is a major U.S. brand of melatonin supplements. Its melatonin products are
`available nationwide at retailers like Walmart, Kroger, and Target. Zarbee’s makes and sells
`melatonin marketed specifically for children (“Zarbee’s Melatonin”). Millions of U.S. consumers
`buy Zarbee’s Melatonin and rely on the accuracy of its labelling. Exhibit 1 identifies the accused
`children’s melatonin products.
`30.
`For each product, the label claims a specific amount of melatonin per unit (1 mg), on
`the back label. For example:
`
`
`13 Madeleine, Poor quality control of over-the-counter melatonin, 13 Journal of Clinical Sleep
`Medicine at 163.
`14 NIH National Center for Complementary and Integrative Health, Melatonin:What You Need
`To Know, https://www.nccih.nih.gov/health/melatonin-what-you-need-to-know
`15 Consumer Reports, New Study Questions Ingredient Levels in Some Melatonin
`Supplements, https://www.consumerreports.org/melatonin/study-questions-ingredient-levels-some-
`melatonin-supplements/
`First Amended Complaint
`
`Case No. 3:22-cv-04465-CRB
`
`7
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`
`

`

`Case 3:22-cv-04465-CRB Document 24 Filed 10/12/22 Page 10 of 31
`
`
`
`
`
`
`31.
`These claims on the back of the product are substantially similar for all accused
`Zarbee’s Melatonin products. They all advertise melatonin as a key active ingredient and claim to
`have the same, specific amount of melatonin (1 mg) per unit. See Exhibit 1.
`32.
`Each Plaintiff and each class member was presented with the materially-identical
`representation on the back of all products.
`
`First Amended Complaint
`
`8
`
`Case No. 3:22-cv-04465-CRB
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`
`

`

`Case 3:22-cv-04465-CRB Document 24 Filed 10/12/22 Page 11 of 31
`
`
`
`33.
`By selling a melatonin supplement for sleep (i.e., a supplement that alters brain
`chemistry), Zarbee’s is representing to consumers that its products are accurately dosed and labelled.
`When a consumer picks up a bottle of Zarbee’s Melatonin, they reasonably expect that it actually has
`the dosage for which Zarbee’s designed the recommended serving. No reasonable consumer expects
`that a melatonin supplement has an unreasonable overdose of melatonin, compared to what it is
`supposed to have. And specifically, when a bottle of Zarbee’s says it has a particular amount of
`melatonin per unit (1 mg), consumers expect this to be accurate (and not unreasonably excessive).
`This is especially true for melatonin marketed for children.
`E.
`Scientific testing reveals that, unlike other manufacturers, Zarbee’s Melatonin
`has an unreasonable excess of melatonin.
`34.
`Liquid Chromatography-Mass Spectrometry analysis (LC-MS) can accurately measure
`the true amount of melatonin in an over-the-counter supplement. LC-MS is a reliable and appropriate
`analytical procedure for measuring melatonin content.
`35.
`For Zarbee’s Melatonin, a university mass-spectrometry laboratory used LC-MS to
`test Zarbee’s Melatonin, among other brands. The lab tested both non-expired bottles and expired
`bottles, from different manufacturing lots (batches).
`36.
`If Zarbee’s Melatonin were reasonably dosed, the amount of melatonin at the end of
`the shelf life (when the bottle expires) would be materially the same as the claim on the label, i.e.,
`close to 100% of the claimed amount. In contrast, if Zarbee’s is unreasonably overdosed, even after a
`bottle expires (i.e., its shelf life is over) there will be materially more melatonin than the amount
`specified on the label. The test results, summarized below, confirm that Zarbee’s has an
`unreasonable excess of melatonin:
`
`
`
`
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`
`First Amended Complaint
`
`9
`
`Case No. 3:22-cv-04465-CRB
`
`

`

`Case 3:22-cv-04465-CRB Document 24 Filed 10/12/22 Page 12 of 31
`
`
`
`Zarbee’s type 16
`
`Claimed
`melatonin dose
`(mg / gummy)
`
`True
`melatonin dose
`(mg / gummy)17
`
`True melatonin
`dose
`(%)18
`
`1.00
`
`2.23
`
`+222%
`
`Zarbee’s Children’s
`Sleep with Melatonin
`Gummies (Expired)
`Lot: FA200901222685
`Exp: 9/2022
`Tested: 8/2022
`Zarbee’s Children’s
`Sleep with Melatonin
`Gummies
`Lot: 2124301250
`Exp: 8/2023
`Tested: 4/2022
`Zarbee’s Children’s
`Sleep with Melatonin
`Gummies
`Lot: FD2108070924519
`Exp: 8/2023
`Tested: 7/2022
`37.
`These results show that the melatonin content of non-expired Zarbee’s is far higher
`than the claimed dosages. For example, Ms. Lopez’s bottle had more than twice the amount of
`melatonin listed on the label.
`38.
`Unsurprisingly, once Zarbee’s Melatonin expires, there is still far too much melatonin,
`compared to the amount claimed on the label. The laboratory tested an expired bottle of Zarbee’s
`Melatonin (Lot# FA20090122268). This bottle expired in September 2022. Yet when it was recently
`tested (just before it expired), it still had 222% of the claimed melatonin content. In other words,
`after expiration, the bottle is still substantially overdosed. Because the excess is materially more than
`reasonably necessary to ensure that the melatonin meets the amount specified on the product label
`throughout the product’s shelf life, Zarbee’s Melatonin is unreasonably overdosed.
`39.
`Zarbee’s own data will confirm that its melatonin products are unreasonably
`overdosed. Dietary supplement manufacturers are required to test the dietary supplements they sell
`
`16 “Lot” is the lot number printed on bottle. “Exp” is the expiration date printed on bottle.
`“Tested” is the month the lab conducted the test.
`17 The lab tested three gummies per bottle and averaged the results. There was little variance
`in the melatonin content between gummies in the same bottle.
`18 The percentage ratio of the true dose to the claimed dose.
`19 Ms. Lopez’s bottle.
`First Amended Complaint
`
`1.00
`
`1.00
`
`1.29
`
`2.16
`
`+128%
`
`+216%
`
`10
`
`Case No. 3:22-cv-04465-CRB
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`
`

`

`Case 3:22-cv-04465-CRB Document 24 Filed 10/12/22 Page 13 of 31
`
`
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`
`for compliance with the FDA’s regulations. That testing must be performed using a random 12-
`sample composite method. 21 C.F.R. § 101.9(g)(2) (describing this method). Manufacturers like
`Zarbee’s must retain the data from these tests. As shown above, in Plaintiff’s testing, all of the
`Zarbee’s samples were substantially overdosed. Accordingly, it is reasonable to infer that Zarbee’s
`own testing (using FDA protocols) will confirm that the products are substantially (and unreasonably)
`overdosed.20
`Zarbee’s labelling is false and misleading to reasonable consumers.
`F.
`40.
`As detailed above, each Zarbee’s Melatonin label claims to have a specific amount of
`melatonin per unit (1mg). But in truth, the dosing is unreasonably excessive. In this way, Zarbee’s
`affirmative representations are misleading to reasonable consumers. For all accused Zarbee’s
`Melatonin, the label is false in the same way.
`41.
`As also detailed above, the inaccurate dosing and labelling of Zarbee’s Melatonin is
`material to reasonable consumers. Consumers need melatonin supplements to be accurately dosed
`and labelled, so that consumers can make an informed choice about what dosage to buy and ingest.
`No reasonable consumer wants to unwittingly buy and ingest a supplement containing an
`unreasonably excessive amount of melatonin, compared to what they thought they were purchasing
`and ingesting. This is especially true for melatonin products marketed to children.
`42.
`Zarbee’s recognizes that its consumers demand accuracy in dosing and labelling.
`Zarbee’s website claims that “Each gummy contains 1 mg melatonin, which is safe” and can “help
`your little one.”21 The point is not that all consumes read the website—the point is that Zarbee’s
`itself admits that accurate dosing and labelling is material to reasonable consumers. Zarbee’s makes
`this claim because it recognizes that consumers want this to be true, i.e., consumers demand products
`that are accurately labelled and dosed. But for Zarbee’s Melatonin, this is not true.
`43.
`Zarbee’s admits that it is undesirable and even dangerous for consumers to ingest
`more melatonin than the recommended dosage on the bottles. Zarbee’s states on its bottles: “Take
`only as directed. Do not exceed recommended dosage.” 22 But due to Zarbee’s inaccurate labelling
`
`20 At this stage, Zarbee’s own testing is uniquely within its own possession.
`21 https://www.zarbees.com/product/childrens-sleep-with-melatonin-gummies/
`
`
`First Amended Complaint
`
`11
`
`Case No. 3:22-cv-04465-CRB
`
`

`

`Case 3:22-cv-04465-CRB Document 24 Filed 10/12/22 Page 14 of 31
`
`
`
`and unreasonably excessive dosing, Zarbee’s customers are unknowingly doing exactly what
`Zarbee’s recommends against (exceeding the recommended dosages).
`44.
`As described above, Zarbee’s claims that it determines the melatonin content of “each
`gummy” to ensure “safety.” And it is a standard practice in the industry for manufacturers to test the
`potency of supplements before they are distributed. Therefore, Zarbee’s reasonably should have
`known that the dosing of Zarbee’s Melatonin is unreasonably excessive, compared to the labels. 23
`45.
`To be clear, while Zarbee’s unreasonably excessive dosing violates the FDC Act,
`Plaintiff is not seeking to enforce the FDC Act itself (i.e., Plaintiff is not suing merely because the
`conduct violates the Act). Zarbee’s false and misleading labeling (and unreasonably excessive
`dosing) is independently illegal under state consumer protection and warranty laws. It is these state
`laws that Plaintiff asserts.
`46.
`Nor is Plaintiff seeking to impose disclosure requirements not required by the FDA.
`Plaintiff wants Zarbee’s to fix its dosing so that it is reasonable (instead of unreasonably excessive)
`and so that its labels are not misleading. This is identical to what the FDC Act and FDA require.
`G.
`Zarbee’s overcharges millions of consumers.
`47.
`Zarbee’s false and misleading labelling drives the demand for Zarbee’s Melatonin. As
`explained above, consumers demand melatonin that is accurately dosed and labelled. This is
`recognized by scientists, Consumer Reports, and Zarbee’s itself. If consumers knew the truth—that
`its dosing and labelling was seriously inaccurate—the price of its products would crater. For
`example, on the Target website, a bottle of Zarbee’s Children’s Sleep with Melatonin Gummies costs
`$16.89. If consumers knew the truth—that this bottle likely has an unreasonably excessive amount of
`melatonin per serving—Zarbee’s could not sell it for anything close to $16.89 (or sell it at all). For
`example, a reasonable consumer who wanted to buy a product with 1 mg of melatonin (for children)
`would not buy an unreasonably overdosed and inaccurately labelled product, and would instead buy a
`reasonably dosed and accurately labeled product. Plaintiff and each class member paid a substantial
`price premium driven by Zarbee’s false and misleading labelling.
`
`
`23 At this stage, Plaintiff is not alleging intentional deception or fraud, but reserve the right to
`amend if discovery reveals evidence of Zarbee’s fraudulent intent.
`First Amended Complaint
`12
`
`Case No. 3:22-cv-04465-CRB
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`
`

`

`Case 3:22-cv-04465-CRB Document 24 Filed 10/12/22 Page 15 of 31
`
`
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`
`48.
`In fact, without accurate dosing and labelling, Zarbee’s Melatonin is worthless. What
`reasonable consumer wants to buy a supplement that alters brain chemistry, if the product is
`inaccurately labelled and unreasonably overdosed? Every reasonable consumer would instead buy an
`accurately dosed and labelled product, so that they could trust what they are getting. Plaintiff and
`each class member paid for Zarbee’s Melatonin products that are, in truth, worthless. Thus, the full
`economic injury here is the entire price of the Zarbee’s Melatonin that Plaintiff and class members
`purchased.
`H. Ms. Lopez was misled and harmed by Zarbee’s misleading labelling.
`49.
`Like millions of other consumers, Ms. Lopez bought Zarbee’s Melatonin and relied on
`the accuracy of Zarbee’s dosing and labelling.
`50.
`In or around early June 2022, Ms. Lopez bought a bottle of Zarbee’s Children’s Sleep
`with Melatonin Gummies (Lot # FD21080709245) from a Walmart in Salinas, to give to her child
`(age 8

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket